Objectives The study aim was to evaluate the predictive role of the echocardiography-
derived tricuspid annular plane systolic excursion/systolic pulmonary artery pressure …

Pulmonary arterial hypertension (PAH) is a rare disease that can be caused by (likely)
pathogenic germline genomic variants. In addition to the most prevalent disease gene …

ABSTRACT Aims The REDUCE‐LAP II trial demonstrated adverse outcomes after interatrial
shunt device (IASD) placement in heart failure with preserved ejection fraction (HFpEF) …

Interest in the pathophysiology, etiology, management, and outcomes of patients with
tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing …

Pulmonary hypertension (PH) is a clinical and pathophysiological syndrome caused by
changes in pulmonary vascular structure or function that results in increased pulmonary …

Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH)
associated with lung disease, and chronic thromboembolic PH cast new light on the …

Pulmonary arterial hypertension (PAH) is a rare disease characterized by pulmonary
vascular remodeling leading to right heart failure and death. To date, despite the three …

Pulmonary hypertension (PH) is a frequent complication of interstitial lung disease (ILD).
Although PH has mostly been described in idiopathic pulmonary fibrosis, it can manifest in …

Signal transducers and activators of transcription 3 (STAT3) signaling plays an important
role in mediating tumor progression, inflammation, cardiovascular disease, and other …

Aims Iron deficiency is common in pulmonary hypertension, but its clinical significance and
optimal definition remain unclear. Methods and results Phenotypic data for 1028 patients …